Dr. Lili Song MD PhD, is the Head of Stroke Program, senior research fellow at The George Institute for Global Health (TGI), and senior lecturer at Faculty of Medicine, University of New South Wales. She has been a neurologist for 15 years and focused on clinical research for more than 10 years. Her research interest is in the treatment and prevention of acute stroke, in particular of blood pressure management and digital management platform after stroke. She currently leads several large-scale clinical trials in stroke area including INTERACT3, INTERACT4, ENCHANTED-MT, Late-MT, CHAIN and ASPIRING as co-PI, co-investigator, Project lead as well as Steering Committee and Executive Committee members. She serves Steering Committee or Data Safety Monitoring Board members for several other large clinical trials (TRIDENT, OPTIMISTmain, PROTECT-MT, and ENRICH-AF). She has successfully awarded as CIB an MRC joint funding in the UK in 2019 as well as an MRFF funding in Australia in 2022. She has published more than 50 publications on high impact clinical journals including NEJM and Lancet (2 Lancet paper as co-first author). She is a reviewer for many high-ranking clinical journals including Lancet, Stroke, Cerebrovascular Diseases, International Journal of Stroke, European Stroke Journal, SVN, TRIALS, etc. She was invited to write editorial or commentary for Lancet Neurology and JAMA. She is supervising 2 PhD students at UNSW. She has been identified as one of 2018 Emerging Leaders by the World Heart Foundation.